Trial Information

Summary: A double-blind, randomized, placebo controlled study of the efficacy, safety & tolerability of 8 week treatment of Rozerem 8 mg (q hs) in sleep disturbed, mild to moderately severe Alzheimer's disease subjects.

Eight week study for patients with Alzheimer's & insomnia.

Patient Inclusion Criteria:

  • Must have Alzheimer's
  • Age >55 yrs
  • Subject has caregiver who is able to sign consent & assist with study procedures

Patient Exclusion Criteria:

  • Subject is non-ambulatory
  • Subject has unstable medical condition

Contact:

Cheryl Rindfleisch
The Roskamp Institute, Clinical Trials Division
2040 Whitfield Ave.
Sarasota, FL 34243
Telephone: 941-256-8018
Fax: 941-758-7146
Email:

Profile Page: The Roskamp Institute, Clinical Trials Division, Sarasota, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:39 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA